Back to search

Article

ARM-X: an Adaptable Mesenchymal Stromal Cell-based Vaccination Plaftorm Suitable for Solid Tumors

2025-04-23

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold> In addition to triggering endosomal escape, the Accum<sup>®</sup> platform was recently reported for its ability to instill antigen cross-presentation properties in mesenchymal stromal cells (MSCs). Despite the promising results obtained with the first-generation vaccine using the A1 Accum<sup>®</sup> derivative (ARM vaccine), large quantities of cancer antigens...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5d418c72-7125-58be-8dde-b5228da1f07d
DOI
10.21203/rs.3.rs-5828115/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
ARM-X: an Adaptable Mesenchymal Stromal Cell-based Vaccination Plaftorm Suitable for Solid TumorsDOI 10.21203/rs.3.rs-5828115/v1
Select a neighboring publication to make it the new centre.